NCT02994069View on ClinicalTrials.gov

Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 11, 2017

Primary Completion Date

September 3, 2024

Study Completion Date

October 31, 2029

Conditions
Carcinoma, Squamous CellHead and Neck Cancer
Interventions
DRUG

Cisplatin

Cisplatin

RADIATION

XRT

Radiation Therapy

Trial Locations (1)

40536

University of Kentucky, Lexington

All Listed Sponsors
lead

Susanne Arnold

OTHER